AGP Executive Report
Last update: 9 hours agoDisease Surveillance: Ebola cases in the Democratic Republic of the Congo have reached 8,787, with 4,242 confirmed deaths, according to WHO figures reported for Oct. 7. Cancer Imaging: A 200-patient study found FAPI PET/CT detected ovarian cancer spread in the abdomen more accurately than conventional CT, potentially helping guide surgery decisions. Drug Development: Merck reported one-year results from its pivotal trial of investigational remigromig for diabetic macular edema; both doses met the trial’s non-inferiority benchmark against ranibizumab, but neither proved superior. Drug Pricing: PhRMA is suing to block a Medicare rule tying some hospital drug prices to costs in other countries, calling it an overreach. Brain Health: A long-term study linked nitrate exposure from tap water and animal products with higher dementia rates, while vegetable-derived nitrates were associated with lower rates; the findings do not prove cause and effect. Drug Safety: A UK watchdog censured CSL Seqirus over more than £730,000 in grants that were undisclosed or did not identify the ultimate recipient.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
